Modeling of Fusarium redolens Dzf2 mycelial growth kinetics and optimal fed-batch fermentation for beauvericin production
- PMID: 21082211
- DOI: 10.1007/s10295-010-0895-2
Modeling of Fusarium redolens Dzf2 mycelial growth kinetics and optimal fed-batch fermentation for beauvericin production
Abstract
Beauvericin (BEA) is a cyclic hexadepsipeptide mycotoxin with notable phytotoxic and insecticidal activities. Fusarium redolens Dzf2 is a highly BEA-producing fungus isolated from a medicinal plant. The aim of the current study was to develop a simple and valid kinetic model for F. redolens Dzf2 mycelial growth and the optimal fed-batch operation for efficient BEA production. A modified Monod model with substrate (glucose) and product (BEA) inhibition was constructed based on the culture characteristics of F. redolens Dzf2 mycelia in a liquid medium. Model parameters were derived by simulation of the experimental data from batch culture. The model fitted closely with the experimental data over 20-50 g l(-1) glucose concentration range in batch fermentation. The kinetic model together with the stoichiometric relationships for biomass, substrate and product was applied to predict the optimal feeding scheme for fed-batch fermentation, leading to 54% higher BEA yield (299 mg l(-1)) than in the batch culture (194 mg l(-1)). The modified Monod model incorporating substrate and product inhibition was proven adequate for describing the growth kinetics of F. redolens Dzf2 mycelial culture at suitable but not excessive initial glucose levels in batch and fed-batch cultures.
Similar articles
-
Statistical optimization of growth medium for the production of the entomopathogenic and phytotoxic cyclic depsipeptide beauvericin from Fusarium oxysporum KFCC 11363P.J Microbiol Biotechnol. 2008 Jan;18(1):138-44. J Microbiol Biotechnol. 2008. PMID: 18239431
-
Beauvericin from the endophytic fungus, Fusarium redolens, isolated from Dioscorea zingiberensis and its antibacterial activity.Nat Prod Commun. 2010 May;5(5):811-4. Nat Prod Commun. 2010. PMID: 20521553
-
Improvement of beauvericin production by Fusarium oxysporum AB2 under solid-state fermentation using an optimised liquid medium and co-cultures.Mycotoxin Res. 2022 Aug;38(3):175-183. doi: 10.1007/s12550-022-00458-y. Epub 2022 Apr 30. Mycotoxin Res. 2022. PMID: 35501595
-
Occurrence, toxicity, bioaccessibility and mitigation strategies of beauvericin, a minor Fusarium mycotoxin.Food Chem Toxicol. 2017 Sep;107(Pt A):430-439. doi: 10.1016/j.fct.2017.07.032. Epub 2017 Jul 15. Food Chem Toxicol. 2017. PMID: 28720287 Review.
-
Beauvericin, A Fusarium Mycotoxin: Anticancer Activity, Mechanisms, and Human Exposure Risk Assessment.Mini Rev Med Chem. 2019;19(3):206-214. doi: 10.2174/1389557518666180928161808. Mini Rev Med Chem. 2019. PMID: 30264680 Review.
Cited by
-
Isolation and Identification of the Antimicrobial Agent Beauvericin from the Endophytic Fusarium oxysporum 5-19 with NMR and ESI-MS/MS.Biomed Res Int. 2016;2016:1084670. doi: 10.1155/2016/1084670. Epub 2016 Jun 19. Biomed Res Int. 2016. PMID: 27413733 Free PMC article.
-
Enhancement of diepoxin ζ production in liquid culture of endophytic fungus Berkleasmium sp. Dzf12 by polysaccharides from its host plant Dioscorea zingiberensis.World J Microbiol Biotechnol. 2012 Apr;28(4):1407-13. doi: 10.1007/s11274-011-0940-y. Epub 2011 Nov 8. World J Microbiol Biotechnol. 2012. PMID: 22805921
-
Beauvericin, a bioactive compound produced by fungi: a short review.Molecules. 2012 Feb 24;17(3):2367-77. doi: 10.3390/molecules17032367. Molecules. 2012. PMID: 22367030 Free PMC article. Review.
-
Integration of Untargeted Metabolomics with Transcriptomics Provides Insights into Beauvericin Biosynthesis in Cordyceps chanhua under H2O2-Induced Oxidative Stress.J Fungi (Basel). 2022 May 6;8(5):484. doi: 10.3390/jof8050484. J Fungi (Basel). 2022. PMID: 35628740 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources